Thomas, Q. D., Firmin, N., Mbatchi, L., Evrard, A., Quantin, X., & Leenhardt, F. (2023). Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. International Journal of Molecular Sciences, 24(6), 5518. https://doi.org/10.3390/ijms24065518
Chicago Style (17th ed.) CitationThomas, Quentin Dominique, Nelly Firmin, Litaty Mbatchi, Alexandre Evrard, Xavier Quantin, and Fanny Leenhardt. "Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key." International Journal of Molecular Sciences 24, no. 6 (2023): 5518. https://doi.org/10.3390/ijms24065518.
MLA (9th ed.) CitationThomas, Quentin Dominique, et al. "Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key." International Journal of Molecular Sciences, vol. 24, no. 6, 2023, p. 5518, https://doi.org/10.3390/ijms24065518.